The identification of a N6-methyladenosin-modifed immune pattern to predict immunotherapy response and survival in urothelial carcinoma
Figure 6. Violin plots (A–U) illustrate the relationship between clinical factors and risk scores, employing the Wilcoxon test for comparisons between two variables and the Kruskal-Wallis test for comparisons among more than two variables.